Vera Therapeutics Inc (VERA) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.87x
Vera Therapeutics Inc (VERA) has a Cash Flow-to-Debt Ratio of -0.87x as of March 2026, meaning its operating cash flow of $-106.50 Million could theoretically repay -1% of its total liabilities ($122.04 Million) in one year. See financial agility of Vera Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.87x
Operating CF / Total Liabilities
Operating Cash Flow
$-106.50 Million
USD
Total Liabilities
$122.04 Million
USD
Data as of
Mar 2026
Most recent filing
Vera Therapeutics Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Vera Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Vera Therapeutics Inc.
Annual Cash Flow-to-Debt Ratio for Vera Therapeutics Inc (2019–2025)
Year-by-year debt coverage analysis for Vera Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.85x | $-241.10 Million | $130.21 Million | ▼ -8.0% |
| 2024 | -1.72x | $-134.68 Million | $78.53 Million | ▼ -37.4% |
| 2023 | -1.25x | $-92.18 Million | $73.86 Million | ▼ -0.7% |
| 2022 | -1.24x | $-67.60 Million | $54.53 Million | ▲ +26.0% |
| 2021 | -1.67x | $-23.71 Million | $14.16 Million | ▼ -592.4% |
| 2020 | -0.24x | $-34.81 Million | $143.90 Million | ▲ +1.4% |
| 2019 | -0.25x | $-10.29 Million | $41.93 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.